Mirza Suljagić

The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling

Mirza Suljagić, Pablo G. Longo, Sara Bennardo et al. · Blood · 2010 · 142 citations · Full text

Medicine, Oncology, Pharmacology +17

Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL

Stefano Iacovelli, Eva Hug, Sara Bennardo et al. · Blood · 2015 · 58 citations · Full text

Medicine, Cancer Biology, Molecular Biology +10

Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells

Mirza Suljagić, Luca Laurenti, Michela Tarnani et al. · Leukemia · 2010 · 29 citations

Life Sciences, Cancer Biology, Oncology +16

Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines

Esma Bilajac, Lejla Mahmutović, Una Glamočlija et al. · Metabolites · 2022 · 17 citations · Full text

Medicine, Cancer Biology, Pharmacology +15

Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells

Una Glamočlija, Lejla Mahmutović, Esma Bilajac et al. · Frontiers in Pharmacology · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacology +9